CN Health Tech Plans HK$51.50 Million Rights Issue; EGM Slated for 12 May 2026

Bulletin Express04-24

CN Health Tech proposes a non-underwritten rights issue to raise up to HK$51.50 million. Shareholders registered on the 22 May 2026 record date will be offered two new shares for every one existing share at HK$0.25 each, a 20.63% discount to the HK$0.315 closing price on the last trading day before announcement. Net proceeds are estimated at HK$50.00 million.

The offer comprises up to 205.85 million Rights Shares, expanding issued share capital to 308.77 million shares if fully taken up. Should any Rights Shares remain unsubscribed, they will be placed on a best-efforts basis through Tiger Faith Securities at not less than the subscription price; shares that are neither subscribed nor placed will be cancelled, reducing the issue size accordingly.

Key dates include: • Last cum-rights trading day: 13 May 2026 • Shares trade ex-rights: 14 May 2026 • Nil-paid Rights trading: 28 May – 4 June 2026 • Latest time to accept and pay: 4:00 p.m., 9 June 2026 • Results announcement: 16 June 2026 • Expected listing of fully-paid Rights Shares: 18 June 2026

Proceeds are earmarked as follows: HK$22.00 million for expanding ginseng plantation capacity, HK$18.00 million for entry into the medical aesthetics sector, and HK$10.00 million for working capital.

The Extraordinary General Meeting to approve the Rights Issue and the placing arrangements will be held on 12 May 2026 in Shenzhen. The register of members closes from 5 to 12 May 2026 for voting eligibility. Completion of the Rights Issue is conditional on shareholder approval and Stock Exchange clearance.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment